Molecular Therapy Nucleic Acids
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.5 | Q1 | 81.2% | 2.068 | Q1 | 95.6% |
| 2024 | 6.1 | Q1 | 83.1% | 2.046 | Q1 | 95.5% |
| 2023 | 6.5 | Q1 | 86.8% | 1.849 | Q1 | 94.9% |
| 2022 | 8.8 | Q1 | 88.5% | 1.947 | Q1 | 95.5% |
| 2021 | 10.2 | Q1 | 89.9% | 1.852 | Q1 | 95.3% |
| 2020 | — | — | 2.208 | Q1 | 96.3% | |
| 2019 | — | — | 2.089 | Q1 | 96.0% | |
| 2018 | — | — | 2.011 | Q1 | 95.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2162-2531
country
UScoverage
2012-2026